INC Research partners with Debiopharm
The partnership allows INC to conduct research work on Debiopharm’s drug development project with the management of a clinical study. The partnership further agrees that the Debiopharm’s future
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.